Hunter Associates Investment Management’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-1,552
| Closed | -$331K | – | 261 |
|
|
2022
Q4 | $331K | Buy |
1,552
+137
| +10% | +$29.2K | 0.08% | 167 |
|
|
2022
Q3 | $274K | Buy |
1,415
+72
| +5% | +$13.9K | 0.07% | 179 |
|
|
2022
Q2 | $279K | Buy |
+1,343
| New | +$279K | 0.07% | 177 |
|
|
2021
Q2 | – | Sell |
-1,370
| Closed | -$397K | – | 152 |
|
|
2021
Q1 | $397K | Sell |
1,370
-55
| -4% | -$15.9K | 0.09% | 145 |
|
|
2020
Q4 | $356K | Sell |
1,425
-88
| -6% | -$22K | 0.09% | 137 |
|
|
2020
Q3 | $343K | Sell |
1,513
-25
| -2% | -$5.67K | 0.1% | 133 |
|
|
2020
Q2 | $268K | Buy |
+1,538
| New | +$268K | 0.08% | 140 |
|